Amgen: Any whispers about restructuring or downsizing?

Hey everyone, been seeing some chatter around the biotech space about potential shifts, and it got me thinking about Amgen. Haven't seen any official news or layoff reports, which is good, but there's definitely a quiet hum. Anyone else in Amgen feeling any pressure, seeing unusual project reprioritization, or hearing any behind-the-scenes talk about team consolidations or role eliminations? It's hard to tell if it's just general industry jitters or something more specific brewing internally. Trying to get a sense of the climate. Curious to hear if anyone has any insights, even anecdotal ones.